BioCentury's websites will be down for upgrades starting at 11 p.m. PDT on Monday, August 26. We expect the downtime to last no more than 6 hours, and we apologize for any inconvenience.

12:00 AM
Feb 21, 2011
 |  BC Week In Review  |  Clinical News  |  Regulatory

Acurox oxycodone regulatory update

FDA accepted for filing and granted Priority Review to an NDA from King Pharmaceuticals Inc., which is being acquired by Pfizer, for Acurox oxycodone without niacin to treat moderate to severe pain. The PDUFA date is June 17. According to...

Read the full 187 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >